Immunomodulators for Asthma.
10.4168/aair.2010.2.4.228
- Author:
Vesselin V DIMOV
1
;
Thomas B CASALE
Author Information
1. Division of Allergy & Immunology, Department of Medicine, Creighton University, Omaha, NE, USA. tbcasale@creighton.edu
- Publication Type:Review ; Clinical Trial
- Keywords:
Asthma;
immunomodulators;
cytokines;
treatment
- MeSH:
Animals;
Asthma;
Cytokines;
Humans;
Immunologic Factors;
Mice
- From:Allergy, Asthma & Immunology Research
2010;2(4):228-234
- CountryRepublic of Korea
- Language:English
-
Abstract:
New information regarding the molecular mechanisms of allergic disorders has led to a variety of novel therapeutic approaches. This article briefly reviews the pathogenesis of asthma and allergic diseases, discusses the rationale behind using immunomodulators in these diseases; and examines the therapeutic effects of immunomodulators on allergic diseases. There are a number of immunomodulators that have been developed for the treatment of allergic disorders. Some have looked very promising in pre-clinical trials, but have not shown significant benefits in human clinical trials thus indicating the disparity between mouse models and human asthma. This review focuses on immunomodulators that are in human clinical trials and not molecules in pre-clinical development.
